Background Whether to treat minor stroke with intravenous tissue plasminogen activator (t-
PA) treatment or antiplatelet therapy is a dilemma. Our study aimed to explore whether …

Rationale The evidence of intravenous thrombolysis in patients with not clearly disabling
minor stroke (low National Institutes of Health Stroke Scale of 0–5) is still insufficient. Recent …

Objectives To compare the safety and efficacy of Dual Antiplatelet Therapy (DAPT) and
Intravenous (IV) Tissue Plasminogen Activator (t-PA) in Acute minor Ischemic Stroke (AIS) …

Background and purpose: The optimal treatment for acute ischemic stroke with mild
neurologic deficits is unclear. We aimed to compare the efficacy and safety of alteplase …

Objective: The objective of this study was to investigate the long-term effect of dual
antiplatelet therapy (DAPT) using clopidogrel plus aspirin versus aspirin monotherapy after …

Background A recent study shows that dual antiplatelet therapy with clopidogrel plus aspirin
is superior to aspirin monotherapy for minor stroke, which is defined as a National Institutes …

The efficacy and safety of dual antiplatelet therapy (DAPT) relative to intravenous (IV)
alteplase in patients with acute minor ischemic stroke are insufficiently established …

Objective: To verify the efficacy and safety of dual antiplatelet therapy after intravenous
thrombolysis for acute minor ischemic stroke (AMIS). Methods: AMIS patients who received …

Importance Intravenous thrombolysis is increasingly used in patients with minor stroke, but
its benefit in patients with minor nondisabling stroke is unknown. Objective To investigate …

Background: Evidence about the use of dual antiplatelet therapy (DAPT) with aspirin and
P2Y12 inhibitors in patients with acute minor ischemic stroke or transient ischemic attack …